Healthcare Service Robots Market is estimated to portray a market valuation of $2.82 Billion by the end of forecasted year to 2025

Global healthcare service robots market is currently witnessing a significant change in the market landscape. There is rising investment in development of healthcare infrastructure, focus toward control of hospital-acquired infections, and deployment of healthcare service robots during the novel coronavirus pandemic. Thus, this is leading to potential growth opportunities for the healthcare service robots market. Moreover, there is an extensive entry of leading medical device players, and software companies into the healthcare space. These companies are integrating their expertise in advanced technologies such as artificial intelligence, machine learning algorithms, and sensors among others into the robotic systems. All these predominant factors have led to a significant rise in sales of healthcare service robots systems across the globe.

The global healthcare service robots market was valued to be $462.3 million in 2019 and is anticipated to witness an impressive double-digit growth rate, to reach $2.82 billion by 2025. The industry is growing multifold owing to the rising investment in development of healthcare infrastructure, focus toward control of hospital-acquired infections, and deployment of healthcare service robots during the novel coronavirus pandemic. Healthcare service domain is also currently exploring the potential of technologies such as artificial intelligence, machine learning algorithms, and sensors among others into the robotic systems. Hence, it is anticipated that these trends will have a significant impact on healthcare service robots market in the next five years, and the market will grow multifold.

Competitive Landscape

The global healthcare service robots is dominated by a plethora robotic companies that can be categorized as manufacturers of robotic systems, and industrial robots such as collaborative robots or cobots. Companies are continuously collaborating with research and medical institutions to expand the service robot space.

In the last five years (January 2016-June 2020), the market witnessed approximately 59 notable key developments. These included 33 product launches, and enhancements 20 synergistic activities, 2 mergers, and acquisitions, 4 funding activities, among others. Most of the companies are significantly undertaking new product development to not only expand their global footprint and offerings in a bid to consolidate the marketplace. Therefore, new offerings constitute the dominant contributors’ strategies.

The key players contributing to the global healthcare service robots market are Xenex Disinfection Services, The UBTECH, Sanbot (QIHAN Technology), UVD Robots (Blue Ocean Robotics), InTouch Health, SoftBank Robotics, Universal Robots A/S, ST Engineering (Aethon), Double Robotics, and UVD Robots, among others.

Key Questions Answered in this Report:

•   What are the various healthcare service robots available in the market?
•   What is the current market size and future potential of these technologies?
•   What are the major market drivers, challenges, and opportunities in the global healthcare service robots market?
•   How is COVID-19 pandemic pushing companies into developing professional service robots?
•   What are the key technological developments on which the current industry leaders are spending a major share of their research and development (R&D) investments?
•   Who are the leading players holding dominating shares in the global healthcare service robots market, currently?
•   What are the key strategies incorporated by the players of global healthcare service robots market, to sustain the competition and retain their supremacy?
•   How are various governments transforming their investment strategies toward strengthening and supporting healthcare service robots for various applications?
•   What is the current revenue contribution of different application types and how would it evolve in the forecast period?
•   What is the current revenue contribution of different utility types and how would it evolve in the forecast period?
•   What is the current revenue contribution of different product types and how would it evolve in the forecast period?
•   What is the current revenue contribution of different technology types and how would it evolve in the forecast period?
•   Which countries contribute to the major share of current demand and which countries hold significant scope for expansion for business activities, by players of the global healthcare service robots market?

Request a Sample - https://bisresearch.com/requestsample?id=959&type=download

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing microbiome therapeutics market is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...

Ligase Market Opportunities, Strategies, Share, Segmentation, In-depth Analysis 2032

The global ligase market is progressing rapidly with a significant increase in the research and development activities pertaining to a wide range of ligase product for disease detection, accentuating their criticality in healthcare. Ligase enzyme has a critical role in the molecular diagnostics approach, as it ensures the safe and effective application of targeted therapeutics. Most of the players in the global ligase market offer products encompassing the ligation kits and enzymes. The global ligase market is projected to reach $651.4 million by 2032 from $371.2 million in 2021, at a CAGR of 5.29% during the forecast period 2022-2032. The growth in the global ligase market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases on a global level, rising awareness of enzyme based diagnostic testing and significant number of funding for executing research and development. Impact Several techniques are employed in ...

PD-1/PDL-1 Inhibitor Market Growth Prospects, Emerging Trends and Forecast to 2032

PD-1/PDL-1 inhibitors are immune-therapeutic agents used in the treatment of various cancer indications, mostly in the advanced stages. PD-1/PDL-1 inhibitors are monoclonal antibodies majorly of IgG1 and IgG4 types to be administered to patients via injection The current market already has seven approved products in the U.S. and a large number of research activities are currently undergoing in this segment generating interest of commercial as well as academic research institutions. In the current period of precision medicine and providing targeted treatment, identification of target patient has become very important as well as complicated. With the emergence of diagnostic test identifying predictive biomarkers, the selection and administration of targeted treatment has become comparativlely conveninent and efficient. PD-1/PDL-1 inhibitors market are majorly indicated for the treatment of advanced cases of different cancer indications. The PD-1/PDL-1 inibitor treatment has ...

Market Research Reports

Search This Blog